| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | LION BIOTECHNOLOGIES INC COM | 3,011,549 | 19,273,000 | 1.89% | ||
| 102 | TESARO INCORPORATED | 636,956 | 19,816,000 | 1.94% | ||
| 103 | HERON THERAPEUTICS INC COM | 1,634,555 | 20,138,000 | 1.98% | ||
| 104 | XENCOR INC COM | 1,740,621 | 20,226,000 | 1.98% | ||
| 105 | Walgreens | 282,000 | 20,905,000 | 2.05% | ||
| 106 | SHIRE PLC | 90,000 | 21,194,000 | 2.08% | ||
| 107 | ZIMMER BIOMET HLDGS INC | 242,500 | 25,186,000 | 2.47% | ||
| 108 | DYAX CORP COM CVR | 2,710,598 | 26,022,000 | 2.55% | ||
| 109 | INSMED INC | 1,800,000 | 35,964,000 | 3.53% | ||
| 110 | Questcor | 400,000 | 36,996,000 | 3.63% | ||
| 111 | AMICUS THERAPEUTICS INC COM | 12,339,444 | 41,214,000 | 4.04% | ||
| 112 | TARO PHARMACEUTICAL INDS LTD | 301,333 | 42,260,000 | 4.15% | ||
| 113 | CELGENE CORP | 507,488 | 43,580,000 | 4.28% | ||
| 114 | VERTEX PHARMACEUTICALS INC | 470,142 | 44,513,000 | 4.37% | ||
| 115 | ACELRX PHARMACEUTICALS INC | 6,574,060 | 67,384,000 | 6.61% | ||
| 116 | NEUROCRINE BIOSCIE COM USD0.001 | 4,599,867 | 68,262,000 | 6.70% | ||
| 117 | SAREPTA THERAPEUTICS INC | 2,558,478 | 76,217,000 | 7.48% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-14-001053, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
